Aptar Pharma and Aceso Therapeutics collaborate to advance inhaled antisense oligonucleotide therapy for cystic fibrosis

Join Pharma | Login

	Editorial


	AN EXPERT VIEW ON LASA DRUGS
	Wednesday, September 2, 2026
	The presence of look-alike and sound-alike (LASA) medicines in the pharmaceutical market in the country has been a major issue the drug authorities have been facing for a long time now.
	Past Editorial...

TODAY'S NEWS


14:00 [IST]	Aptar Pharma and Aceso Therapeutics collaborate to advance inhaled antisense oligonucleotide therapy for cystic fibrosis
13:45 [IST]	Indoco Remedies receives 7 US FDA observations for Goa facility
13:00 [IST]	Skylab unveils clinical data of CART blood pressure monitor for for AF and HF patients at ESC Congress
12:00 [IST]	Rezubio gets US FDA & Chinese NMPA clearances and first cohort dosing of RZ-520, a novel inhaled therapy for chronic respiratory diseases
11:45 [IST]	Sanofi signs letter of intent with Tricog Health to power next generation of health innovators
11:30 [IST]	Manipal Hospital Bhubaneswar marks world physiotherapy day with focus on healthy ageing

more news >>

TOP NEWS


08:00 [IST]	Parliamentary Panel recommends policy, regulatory steps to strengthen Ayush services
08:00 [IST]	KSRPA calls for IPS-led special enforcement team to crack down on quacks and illegal drug sales
08:00 [IST]	DGFT opens CoO API integration for pharma exporters towards ease of doing business
08:00 [IST]	AIOCD demands balanced growth to protect 12.4 lakh chemists amid pharma market value expansion
08:00 [IST]	Indian pharma turns towards equipment with hygienic design, certified materials as global regulators tighten scrutiny
08:00 [IST]	NPPA seeks data for ceiling price fixation of certain IV fluids

more news >>

YESTERDAY'S NEWS


17:45 [IST]	ASG Hospital deepens ophthalmic talent pool with latest fellowship batch
17:35 [IST]	From tradition to innovation, Ayurveda can shape a healthier tomorrow: Prataprao Jadhav
17:30 [IST]	Tech Mahindra partners with PeaceHealth to build AI-driven healthcare ecosystem
17:15 [IST]	REGEN 2026 features internationally developed BMAC Consensus Guidelines in regenerative orthopedics
15:50 [IST]	India must build on its strength in generics to become a global leader in complex & high-value medicines: Piyush Goyal
15:10 [IST]	Piyush Goyal calls for resilient pharma supply chains, global investment and stronger R&D

more news >>

INTERVIEW


Uzbekistan offers one of the most dynamic and strategically positioned pharmaceutical markets in Eurasia: Abdulla Azizov
Abdulla Azizov, Chairman of the Medical and Pharmaceutical Industry Development Agency and the First Deputy Minister of Health of the Republic of Uzbekistan

Past Interviews...

	What's New?

FDA Approved Drug Products Approval List July 2026 FDA Approved Drug Products Approval List June 2026 FDA Approved Drug Products Approval List May 2026 FDA Approved Drug Products Approval List April 2026 FDA Approved Drug Products Approval List March 2026

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers